HCV replication in PBMC and its influence on interferon therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

296

HTML

2432

Figures (1-2)

106

Tables (1-2)

119

Sum=2953

Feb 15, 2003 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Feb 15, 2003; 9(2): 291-294
Published online Feb 15, 2003. doi: 10.3748/wjg.v9.i2.291

Table 1 HCV plus and minus RNA and HCVNS5 in PBMCs

^bComparison of the detection rates of HCV minus-RNA between acute and chronic hepatitis C, u = 2.07, P < 0.05;

^dComparison of the detection rates of HCV NS5 protein between acute and chronic hepatitis C, u = 4.43, P < 0.01.

Citation: Gong GZ, Lai LY, Jiang YF, He Y, Su XS. HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol 2003; 9(2): 291-294
URL: https://www.wjgnet.com/1007-9327/full/v9/i2/291.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i2.291